Trial Details

Not Recruiting
Basic Information
Clinical ID c3201
Identifier NL-OMON39090
Trial Title A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS - A3921096 (9002/008), OCTAVE Sustain
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions inflammatory bowel disease Ulcerative Colitis;10017969
Interventions Subjects will be equally randomized to one of the three treatment groups: Tofacitinib 10 mg BID orally. Tofacitinib 5 mg BID orally. Placebo BID orally.
Participant Information
Sponsor Pfizer
City -
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -